LCMV-GP Pseudotyped Oncolytic Vesicular Stomatitis Virus for the Treatment of Prostate and Ovarian Cancer

Urbiola C. R.; Dold C.; Kimpel J.; Santer F.; Culig Z.; Muik A.; Marth C.; von Laer D.

首页> 外文期刊>Human gene therapy >LCMV-GP Pseudotyped Oncolytic Vesicular Stomatitis Virus for the Treatment of Prostate and Ovarian Cancer

【24h】

LCMV-GP Pseudotyped Oncolytic Vesicular Stomatitis Virus for the Treatment of Prostate and Ovarian Cancer

机译：LCMV-GP假型溶瘤性水疱性口腔炎病毒用于治疗前列腺癌和卵巢癌

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Human gene therapy》 |2014年第12期|共2页
作者
Urbiola C. R.; Dold C.; Kimpel J.; Santer F.; Culig Z.; Muik A.; Marth C.; von Laer D.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献
中文文献
专利

1. LCMV-GP Pseudotyped Oncolytic Vesicular Stomatitis Virus for the Treatment of Prostate and Ovarian Cancer [J] . Urbiola C. R., Dold C., Kimpel J., Human gene therapy . 2014,第12期

机译：LCMV-GP假型溶瘤性水疱性口腔炎病毒用于治疗前列腺癌和卵巢癌
2. MAP3K7 and CHD1 Are Novel Mediators of Resistance to Oncolytic Vesicular Stomatitis Virus in Prostate Cancer Cells [J] . Robert S. Bayne, Shelby Puckett, Lindsey Ulkus Rodrigues, Molecular Therapy - Oncolytics . 2020,第3期

机译：MAP3K7和CHD1是前列腺癌细胞中抗氯腹腔炎病毒的新型抗抗性培养蛋白
3. Evaluation of vesicular stomatitis virus mutant as an oncolytic agent against prostate cancer [J] . Xin Zhao, Shengsong Huang, Huarong Luo, International Journal of Clinical and Experimental Medicine . 2014,第5期

机译：评价水泡性口炎病毒突变体作为抗前列腺癌的溶瘤剂
4. Retroviral Vectors Pseudotyped with Chimeric Vesicular Stomatitis Virus Glycoprotein for Antibody-Dependent Gene Transduction [C] . Yujiro Kameyama, Yoshinori Kawabe, Akira Ito, Annual and International Meeting of the Japanese Association for Animal Cell Technology . 2010

机译：逆转录载体与嵌合杂质口炎病毒糖蛋白拷贝型依赖于抗体依赖性基因转导
5. MAP3K7 and CHD1 are Novel Mediators of Resistance to Oncolytic Vesicular Stomatitis Virus in Prostate Cancer [D] . Bayne, Robert S. 2019

机译：MAP3K7和CHD1是前列腺癌中抗氯腹腔炎病毒的新型抗抗腐蚀性介质
6. Natural killer T cell immunotherapy combined with oncolytic vesicular stomatitis virus or reovirus treatments differentially increases survival in mouse models of ovarian and breast cancer metastasis [O] . Simon Gebremeskel, Adam Nelson, Brynn Walker, 2021

机译：天然杀手T细胞免疫疗法与肉毒状的凹凸炎病毒或reovirus治疗相结合差异增加了卵巢和乳腺癌转移的小鼠模型中的存活
7. Natural killer T cell immunotherapy combined with oncolytic vesicular stomatitis virus or reovirus treatments differentially increases survival in mouse models of ovarian and breast cancer metastasis [O] . Simon Gebremeskel, Adam Nelson, Brynn Walker, 2021

机译：天然杀手T细胞免疫疗法与肉毒状的凹凸炎病毒或reovirus治疗相结合，差异增加了卵巢和乳腺癌转移的小鼠模型中的存活
8. Construction of a Vesicular Stomatitis virus Expressing Both a Fusogenic Glycoprotein and IL-12: A Novel Vector for Prostate Cancer Therapy [R] . 2007

机译：表达融合糖蛋白和IL-12的水泡性口炎病毒的构建：一种用于前列腺癌治疗的新型载体

LCMV-GP Pseudotyped Oncolytic Vesicular Stomatitis Virus for the Treatment of Prostate and Ovarian Cancer

著录项

相似文献

相关主题

期刊订阅